Related Experiment Video
Updated: Jul 18, 2025
12:17
Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
Published on: May 21, 2017
11.4K
Optimizing aortic valve prosthesis selection in patients with obesity: Institutional experience with
Ozan Onur Balkanay1, Halil Ibrahim Bulut2, Ergida Albrahimi1
1Department of Cardiovascular Surgery Cerrahpasa School of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.
Asian Cardiovascular & Thoracic Annals
|August 23, 2023
Summary
For obese patients undergoing aortic valve replacement, neither bioprosthetic nor mechanical valves showed significant differences in outcomes. Careful consideration of valve choice is still recommended for this population.
Area of Science:
- Cardiology
- Surgical Innovation
- Obesity Medicine
Background:
- Aortic valve diseases are prevalent and life-threatening, with obesity as a significant risk factor.
- Current guidelines lack specific management strategies for aortic valve disease in obese patients.
- The optimal choice of prosthetic valve in obese individuals remains unclear.
Purpose of the Study:
- To compare the outcomes of bioprosthetic versus mechanical aortic valve replacement in patients with obesity.
- To evaluate perioperative characteristics and follow-up results in this specific patient cohort.
Main Methods:
- A total of 130 obese patients underwent surgical aortic valve replacement.
- Patients were divided into two groups: 50 received bioprosthetic valves, and 80 received mechanical valves.
- Perioperative characteristics and follow-up results were compared between the groups.
Main Results:
- No significant differences were observed in patient demographics, preoperative conditions, or intraoperative characteristics between the bioprosthetic and mechanical valve groups.
- Postoperative outcomes, including mortality and acute kidney injury, did not significantly differ between the groups.
- Intensive care unit (ICU) stays were shorter for bioprosthetic valve recipients, though not statistically significant.
Conclusions:
- Valve selection for obese patients, especially those with class II obesity, requires careful consideration.
- Obesity's impact on valve choice and the potential for future bariatric surgery should be factored into decisions.
Keywords:
Aortic valvebioprostheticbloodcardiaccoagulation/anticoagulationegetc.)heart valve prosthesis (specify typemechanicalobesity (incl related subjects)replacementMore Related Videos
Related Concept Videos
01:25Aortic Regurgitation III: Medical Management
25
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
25
01:26Mitral Stenosis III: Medical Management
13
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
13
01:22Mitral Valve Prolapse II: Assessment and Management
22
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
22
01:25Mitral Regurgitation III: Medical Management
18
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
18
01:19Mitral Valve Prolapse III: Nursing Management
16
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
16
01:27Mitral Stenosis IV: Nursing Management
14
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
14